Application 012093
- Type
- NDA
- Sponsor
- BAUSCH
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | ISORDIL | ISOSORBIDE DINITRATE | TABLET;ORAL | 40MG | Yes | Yes |
| 002 | ISORDIL | ISOSORBIDE DINITRATE | TABLET;ORAL | 10MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** | Yes | No |
| 005 | ISORDIL | ISOSORBIDE DINITRATE | TABLET;ORAL | 30MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** | Yes | No |
| 006 | ISORDIL | ISOSORBIDE DINITRATE | TABLET;ORAL | 20MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** | Yes | No |
| 007 | ISORDIL | ISOSORBIDE DINITRATE | TABLET;ORAL | 5MG | Yes | No |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 0187-0152 | Isordil | isosorbide dinitrate | Valeant Pharmaceuticals North America LLC | NDA | Current |
| 0187-0152 | Isordil | isosorbide dinitrate | Bausch Health Americas, Inc | NDA | Current |
| 0187-0152 | Isordil | isosorbide dinitrate | Bausch Health US LLC | NDA | Current |
| 0187-0152 | Isordil | isosorbide dinitrate | Bausch Health US LLC | NDA | Current |
| 0187-0192 | Isordil | isosorbide dinitrate | Valeant Pharmaceuticals North America LLC | NDA | Current |
| 0187-0192 | Isordil | isosorbide dinitrate | Bausch Health Americas, Inc | NDA | Current |
| 0187-0192 | Isordil | isosorbide dinitrate | Bausch Health US LLC | NDA | Current |
| 0187-0192 | Isordil | isosorbide dinitrate | Bausch Health US LLC | NDA | Current |
| 68682-192 | Isosorbide Dinitrate | isosorbide dinitrate | Oceanside Pharmaceuticals | NDA | Current |
| 68682-193 | Isosorbide Dinitrate | isosorbide dinitrate | Oceanside Pharmaceuticals | NDA | Current |